Ilerimplant’s overall goals with this innovation project are to industrialise and to introduce in the market a new generation of osteoinductive dental implants based on this sol-gel coating (SolDent). In order to reach full commercialisation of SolDent dental implants, a...
Ilerimplant’s overall goals with this innovation project are to industrialise and to introduce in the market a new generation of osteoinductive dental implants based on this sol-gel coating (SolDent). In order to reach full commercialisation of SolDent dental implants, a technical and economic feasibility study have been performed. With this study, we reduced the risk of our business intentions through the incorporation of the new osteoinductive dental implants to our product portfolio. Furthermore, the study performed focuses on the industrialisation process, regulatory issues and commercialisation strategy including the elaboration of a comprehensive business plan at the end.
The work developed during Phase 1 is the following:
1. A comprehensive analysis of the regulation. This analysis addressed the search for standards and regulations that will be required in order to ensure the CE Marking of the dental implant as a medical device. Furthermore, the completion of all preclinical tests at the same time as this feasibility study was considered convenient in order to minimize risks. On the other hand, the first steps of the integration of sol-gel process in plant were done. This first integration allowed a small-scale production with an acceptable level of quality.
2. A market analysis to reinforce the knowledge about the new markets where the company envisages its introduction. To this purpose, surveys were conducted among our current distributor network, including as many final customers (dentists) as possible, in order to present the new product and assess the level of acceptance, ensuring that the estimated impact for the company is aligned with reality. Moreover, we carried out an analysis of both possible competitors and distributors for new agreements.
3. From the information obtained during the previous activities, the marketing and commercialisation strategy was defined in order to reach those markets defined as targets with our new product, especially European markets.
4. A detailed operational plan was defined once the business objectives were set. In this stage we have analysed both the new resources of operational structure needed, and the investment requirements to suit the production capacity.
5. A financial plan was developed to analyse the financial feasibility of the present project. We have exhaustively calculated the required investment for both the initial development and the production capacity adaptation of the company to the commercial objectives of the new product throughout time.
The results of the technical and economic feasibility study are highly satisfactory. For this reason, ILERIMPLANT will pursue the development and launch of the new implant concept. Furthermore, it is planned to submit a proposal for the Phase 2 of the SME Instrument in order to continue with the demonstration of the SolDent implant.
More info: http://www.ilerimplant.com/en/the-news/257-proyecto-horizon-2020-de-la-comisi.